Clinical Trials Browser

Hydroxyurea × Lymphoid × 90 days × Clear all

NCT05020652 2026-06-02

A Clinical Trial of TQ05105 Tablets in the Treatment of Moderate and High Risk Myelofibrosis

Phase 2 Completed

Lymphoma, Follicular